Arcadia Biosciences (RKDA)

Overall impact
C (59)

Commentary

Arcadia Biosciences is an average overall performer. With a 'C' rating of 59.1 for overall impact (61st percentile compared to all companies), Arcadia Biosciences ranks 4th out of 11 industry peers, behind Marrone Bio Innovations, Calyxt and Senestech, and ahead of Mosaic, American Vanguard, CF Industries and 4 others. On top material causes for Arcadia Biosciences's industry (Chemicals), Arcadia Biosciences performs well in Humane Treatment of Animals (96.2 score) and performs poorly in Sanitation Access (39.9 score) and Reduced Green House Gas Emissions (17.9).
Impact
Cause RKDA
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
8
Sector
Materials
Industry
Chemicals
Sub-industry
Fertilizers & Agricultural Chemicals
SASB industry
Chemicals
Headquarters
Tx, United States
Share classes
RKDA
Description
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body care products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Material causes
Ethos considers the following causes material for Arcadia Biosciences, based on its industry sub-industry Fertilizers & Agricultural Chemicals. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.